miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2

Author:

Li Xiao-Na1,Yang Hong2,Yang Tao3

Affiliation:

1. The Department of General Surgery, Tongde Hospital of Zhejiang ProvinceZhejiang ProvinceP.R. China

2. The Department of Medical Oncology, The First Hospital of ShijiazhuangShijiazhuang, Hebei ProvinceP.R. China

3. The Department of Hepatological Surgery, Tongde Hospital of Zhejiang ProvinceZhejiang ProvinceP.R. China

Abstract

In the present study, we investigated the role of miR-122 in hepatocarcinoma progression and explored the mechanism. In hepatocarcinoma tissues and cells, we used qRT-PCR to validate the miR-122 expression level. Next, we used colony formation by crystal violet staining assay to compare cell proliferation ability, and we used scratch test or Transwell assay to compare cell migration or invasion ability. We then conducted bioinformatics or luciferase reporter gene assay to prove the regulation effect of miR-122 on lamin B2 (LMNB2), and the biological function of LMNB2 was analyzed. We used nude mouse tumorigenicity assay to test the inhibition effect of miR-122 ASO therapy against hepatocarcinoma. miR-122 was reduced in hepatocarcinoma tissues compared to the paracarcinoma tissues, which was relatively low or high in hepatocarcinoma cell line SMMC7721 or Hep3B, and overexpressed miR-122 inhibited proliferation, migration, and invasion in hepatocarcinoma cells. Additionally, some reports showed that LMNB2 was regulated by miR-122, which inhibited the expression of LMNB2. Moreover, LMNB2 functioned to promote cell proliferation, migration, and invasion. We could achieve the inhibition of hepatocarcinoma using miR-122 therapy through decreasing LMNB2 expression in vivo. Our data indicated that miR-122 could inhibit hepatocellular carcinoma cell progression by targeting LMNB2 and as a therapeutic target for hepatocarcinoma treatment.

Publisher

Cognizant, LLC

Subject

Cancer Research,Oncology,General Medicine

Reference53 articles.

1. Cancer statistics, 2017;CA Cancer J Clin.,2017

2. miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3;PLoS One,2013

3. WNT1 gene from WNT signaling pathway is a direct target of miR-122 in hepatocellular carcinoma;Appl Biochem Biotechnol.,2017

4. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma;J Transl Med.,2016

5. Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma;Am J Cancer Res.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3